|
Abarelix for the Treatment of Prostate Cancer
|
|
Actinic Keratoses
|
|
Acupuncture for Fibromyalgia
|
|
Acupuncture for Nausea after Chemotherapy and Post-operative Pain
|
|
Acupuncture for Osteoarthritis
|
|
Air-Fluidized Beds for Pressure Ulcers
|
|
Air-Fluidized Beds for Pressure Ulcers (1st Recon)
|
|
Ambulatory Blood Pressure Monitoring
|
|
Ambulatory Blood Pressure Monitoring (1st Recon)
|
|
Anticancer Chemotherapy for Colorectal Cancer
|
|
Aprepitant for Chemotherapy-Induced Emesis
|
|
Arthroscopy for the Osteoarthritic Knee
|
|
Artificial Hearts
|
|
Augmentative and Alternative Communication (AAC) Devices for Speech Impairment
|
|
Autologous Blood Derived Products for Chronic Non-Healing Wounds (2nd Recon)
|
|
Autologous Blood-Derived Products for Chronic Non-Healing Wounds
|
|
Autologous Stem Cell Transplantation (AuSCT) for Amyloidosis (1st Recon)
|
|
Autologous Stem Cell Transplantation (AuSCT) for Multiple Myeloma
|
|
Autologous Stem Cell Transplantation (AuSCT) for Multiple Myeloma (1st Recon)
|
|
Autologous Stem Cell Transplantation for AL Amyloidosis
|
|
Bariatric Surgery for the Treatment of Morbid Obesity (1st Recon)
|
|
Biofeedback for Urinary Incontinence
|
|
Blood Brain Barrier Disruption (BBBD) Chemotherapy
|
|
Breast Biopsy
|
|
Breast Biopsy (Percutaneous Image Guided) for Palpable Lesions
|
|
Cardiac Catheterization Performed In Other Than A Hospital Setting
|
|
Cardiac Pacemakers
|
|
Cardiac Pacemakers (1st Recon)
|
|
Cardiac Pacemakers (2nd Recon)
|
|
Cardiac Rehabilitation
|
|
Cardiac Rehabilitation Programs (1st Recon)
|
|
Carotid Artery Stenting (1st Recon)
|
|
Carotid Artery Stenting in Post-Approval Studies
|
|
Cavernous Nerves Electrical Stimulation with Penile Plethysmography
|
|
Clinical Trial Policy (1st Recon)
|
|
Clinical Trial Policy (2nd Recon)
|
|
Cochlear Implantation
|
|
Computed Tomographic Angiography
|
|
Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)
|
|
Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) (1st Recon)
|
|
Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) (2nd Recon)
|
|
Cryosurgery Ablation for Prostate Cancer
|
|
Cryosurgical Salvage Therapy for Recurrent Prostate Cancer
|
|
Deep Brain Stimulation for Parkinson's Disease
|
|
Diabetic Peripheral Neuropathy with Loss of Protective Sensation (LOPS)
|
|
Electrical Bioimpedance for Cardiac Output Monitoring
|
|
Electrical Bioimpedance for Cardiac Output Monitoring (1st Recon)
|
|
Electrical Bioimpedance for Cardiac Output Monitoring (2nd Recon)
|
|
Electrical Stimulation for Fracture Healing
|
|
Electrocardiographic Services
|
|
Electrodiagnostic Sensory Nerve Conduction Threshold
|
|
Electrodiagnostic Sensory Nerve Conduction Threshold (1st Recon)
|
|
Electrostimulation for Wounds
|
|
Electrostimulation for Wounds (1st Recon)
|
|
Erythropoiesis Stimulating Agents (ESAs) for non-renal disease indications
|
|
External Counterpulsation (ECP) Therapy
|
|
External Counterpulsation (ECP) Therapy (1st Recon)
|
|
External Counterpulsation (ECP) Therapy (2nd Recon)
|
|
Extracorporeal Immunoadsorption Using Protein A Columns for Rheumatoid Arthritis
|
|
Extracorporeal Photopheresis (1st Recon)
|
|
Ferrlecit®: Intravenous Iron Therapy
|
|
Heartsbreath Test for Heart Transplant Rejection
|
|
Helicobactor Pylori Testing for Ulcers
|
|
Home Biofeedback For Urinary Incontinence
|
|
Home Blood Glucose Monitors
|
|
Home Use of Oxygen
|
|
Human Tumor Assay Systems
|
|
Hyperbaric Oxygen Therapy for Hypoxic Wounds and Diabetic Wounds of the Lower Extremities
|
|
Implantable Cardioverter Defibrillators (ICDs)
|
|
Implantable Defibrillators (2nd Recon)
|
|
Implantable Defibrillators (3rd Recon)
|
|
Implantable Defibrillators - Clinical Trials (1st Recon)
|
|
Infrared Therapy Devices
|
|
Insulin Infusion Pump
|
|
Insulin Pump: C-Peptide Levels as a Criterion for Use
|
|
Insulin Pump: C-Peptide Levels as a Criterion for Use (1st Recon)
|
|
Intestinal and Multi-visceral Transplantation (1st Recon)
|
|
Intestinal and Multivisceral Transplantation
|
|
Intracranial Stenting and Angioplasty (2nd Recon)
|
|
Intracranial Stenting and Angioplasty (5th Recon)
|
|
Intravenous Immune Globulin for Autoimmune Mucocutaneous Blistering Diseases
|
|
Levocarnitine for End Stage Renal Disease
|
|
Lipid Testing (Clarification of ICD-9-CM Codes for Hypertension)
|
|
Liver Transplantation
|
|
Liver Transplantation for Malignancies
|
|
Liver Transplantation for Malignancies other than Hepatocellular Carcinoma
|
|
Liver Transplants in Non-approved Centers During the Emergency in Houston
|
|
Liver Transplants in Non-approved Centers During the Emergency in Houston (Amendment) (1st Recon)
|
|
Lumbar Artificial Disc Replacement
|
|
Lumbar Artificial Disc Replacement (LADR) (1st Recon)
|
|
Lung Volume Reduction Surgery (1st Recon)
|
|
Lung Volume Reduction Surgery (2nd Recon)
|
|
Lymphedema Pumps
|
|
Magnetic Resonance Angiography of the Abdomen and Pelvis
|
|
Magnetic Resonance Spectroscopy for Brain Tumors
|
|
Medical Nutrition Therapy Benefit for Diabetes & ESRD
|
|
Microvolt T-wave Alternans
|
|
Microvolt T-wave Alternans (1st Recon)
|
|
Mobility Assistive Equipment
|
|
Multiple-Seizure Electroconvulsive Therapy
|
|
Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases
|
|
Nesiritide for Treatment of Heart Failure Patients
|
|
Neuromuscular Electrical Stimulation (NMES) for Spinal Cord Injury (1st Recon)
|
|
Non-Autologous Blood Derived Products for Chronic Non-Healing Wounds (1st Recon)
|
|
Noninvasive Positive Pressure RADs for COPD
|
|
Obesity as an Illness
|
|
Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration
|
|
Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration (1st Recon)
|
|
Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration (2nd Recon)
|
|
Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration (3rd Recon)
|
|
Pancreas Transplants (1st Recon)
|
|
Pelvic Floor Electrical Stimulation for Urinary Incontinence
|
|
Percutaneous Transluminal Angioplasty (PTA) and Stenting of the Renal Arteries (4th Recon)
|
|
Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting
|
|
Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting (3rd Recon)
|
|
Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting (6th Recon)
|
|
Pneumatic Compression Pumps for Venous Insufficiency
|
|
Positron Emission Tomography (FDG)
|
|
Positron Emission Tomography (FDG) and Other Neuroimaging Devices for Suspected Dementia (1st Recon)
|
|
Positron Emission Tomography (FDG) for Alzheimer's Disease/Dementia
|
|
Positron Emission Tomography (FDG) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers
|
|
Positron Emission Tomography (FDG) for Breast Cancer
|
|
Positron Emission Tomography (FDG) for Infection and Inflammation
|
|
Positron Emission Tomography (FDG) for Myocardial Viability
|
|
Positron Emission Tomography (FDG) for Soft Tissue Sarcoma (STS)
|
|
Positron Emission Tomography (FDG) for Thyroid Cancer
|
|
Positron Emission Tomography (N-13 Ammonia) for Myocardial Perfusion
|
|
Positron Emission Tomography Scanner Technology
|
|
Prolotherapy for Chronic Low Back Pain
|
|
Prothrombin Time (INR) Monitor for Home Anticoagulation Management
|
|
Prothrombin Time (INR) Monitor for Home Anticoagulation Management (1st Recon)
|
|
Pulmonary Rehabilitation
|
|
Radioimmunotherapy for Non-Hodgkin's Lymphoma
|
|
Sacral Nerve Stimulation for Urge Urinary Incontinence
|
|
Screening DNA Stool Test for Colorectal Cancer
|
|
Screening Immunoassay Fecal-Occult Blood Test
|
|
Serum Iron Studies (Addition of Restless Leg Syndrome as a Covered Indication) (1st Recon)
|
|
Smoking & Tobacco Use Cessation Counseling
|
|
Stem Cell Transplantation (1st Recon)
|
|
Thermal Intradiscal Procedures
|
|
Transmyocardial Revascularization for Severe Angina
|
|
Transplant Centers: Re-Evaluation of Criteria for Medicare Approval
|
|
Tumor Antigen by Immunoassay CA 125 (Addition of Primary Peritoneal Adenocarcinoma as a Covered Indication) (1st Recon)
|
|
Ultrasound Diagnostic Procedures (1st Recon)
|
|
Ultrasound Stimulation for Nonunion Fracture Healing
|
|
Ultrasound Stimulation for Nonunion Fracture Healing (1st Recon)
|
|
Vagus Nerve Stimulation for Treatment of Resistant Depression (TRD) (1st Recon)
|
|
Venofer: Intravenous Iron Therapy
|
|
Ventricular Assist Devices (VADs) as a Bridge to Heart Transplantation
|
|
Ventricular Assist Devices as Destination Therapy
|
|
Ventricular Assist Devices as Destination Therapy (1st Recon)
|
|
Warm-Up Wound Therapy® a/k/a Noncontact Normothermic Wound Therapy (NNWT)
|
|
Wheelchairs
|
Email
Print